$ICUI
ICU Medical Inc

2012 Q4 Form 10-Q Financial Statement

#000088398412000103 Filed on October 19, 2012

View on sec.gov

Income Statement

Concept 2012 Q4 2012 Q3 2011 Q3
Revenue $82.67M $81.41M $76.46M
YoY Change 8.11% 6.47% 1.29%
Cost Of Revenue $40.90M $40.71M $40.88M
YoY Change 0.99% -0.43% -1.97%
Gross Profit $41.77M $40.70M $35.57M
YoY Change 16.17% 14.4% 5.32%
Gross Profit Margin 50.52% 49.99% 46.53%
Selling, General & Admin $20.70M $20.18M $20.41M
YoY Change -7.17% -1.15% 11.29%
% of Gross Profit 49.56% 49.58% 57.38%
Research & Development $2.200M $2.988M $1.877M
YoY Change 0.0% 59.19% 75.91%
% of Gross Profit 5.27% 7.34% 5.28%
Depreciation & Amortization $4.700M $4.800M $4.600M
YoY Change 2.17% 4.35% 9.52%
% of Gross Profit 11.25% 11.8% 12.93%
Operating Expenses $23.00M $23.17M $22.29M
YoY Change -5.74% 3.93% 14.84%
Operating Profit $18.77M $17.53M $13.29M
YoY Change 62.45% 31.94% -9.15%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $100.0K $158.0K $132.0K
YoY Change -50.0% 19.7% -161.4%
Pretax Income $18.90M $17.69M $13.42M
YoY Change -27.31% 31.82% -6.88%
Income Tax $6.600M $5.500M $4.157M
% Of Pretax Income 34.92% 31.09% 30.98%
Net Earnings $12.34M $12.19M $9.261M
YoY Change -30.82% 31.61% 5.04%
Net Earnings / Revenue 14.93% 14.97% 12.11%
Basic Earnings Per Share $0.86 $0.85 $0.66
Diluted Earnings Per Share $0.82 $0.82 $0.65
COMMON SHARES
Basic Shares Outstanding 14.59M shares 14.32M shares 13.93M shares
Diluted Shares Outstanding 14.83M shares 14.18M shares

Balance Sheet

Concept 2012 Q4 2012 Q3 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $226.2M $204.3M $119.1M
YoY Change 41.38% 71.54% 45.42%
Cash & Equivalents $146.9M $127.5M $122.1M
Short-Term Investments $79.30M $76.80M $52.20M
Other Short-Term Assets $11.60M $10.10M $13.30M
YoY Change 6.42% -24.06% 20.91%
Inventory $36.33M $37.59M $43.36M
Prepaid Expenses
Receivables $49.13M $53.01M $53.08M
Other Receivables $2.300M $7.600M $8.500M
Total Short-Term Assets $325.5M $312.6M $237.3M
YoY Change 25.0% 31.75% 21.43%
LONG-TERM ASSETS
Property, Plant & Equipment $85.94M $83.64M $86.72M
YoY Change 0.0% -3.55% 3.48%
Goodwill $1.478M $1.478M $1.478M
YoY Change 0.0% 0.0%
Intangibles $9.952M $10.42M $11.71M
YoY Change -12.85% -11.01%
Long-Term Investments
YoY Change
Other Assets $5.600M $4.800M $6.300M
YoY Change 16.67% -23.81% 70.27%
Total Long-Term Assets $103.0M $100.3M $106.2M
YoY Change 2.29% -5.59% 1.18%
TOTAL ASSETS
Total Short-Term Assets $325.5M $312.6M $237.3M
Total Long-Term Assets $103.0M $100.3M $106.2M
Total Assets $428.5M $412.9M $343.5M
YoY Change 18.66% 20.2% 14.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.31M $12.17M $11.21M
YoY Change -14.66% 8.53% -7.36%
Accrued Expenses $17.81M $16.75M $12.88M
YoY Change 10.9% 30.04% -9.32%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $29.12M $28.91M $24.09M
YoY Change -0.66% 20.03% -9.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.300M $3.800M $4.500M
YoY Change -19.51% -15.56% 2.27%
Total Long-Term Liabilities $3.300M $3.800M $4.500M
YoY Change -19.51% -15.56% 2.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.12M $28.91M $24.09M
Total Long-Term Liabilities $3.300M $3.800M $4.500M
Total Liabilities $37.70M $39.90M $36.60M
YoY Change -6.91% 9.02% -3.94%
SHAREHOLDERS EQUITY
Retained Earnings $342.2M $329.8M $285.6M
YoY Change 13.72% 15.47%
Common Stock $65.26M $63.74M $57.91M
YoY Change 11.97% 10.07%
Preferred Stock
YoY Change
Treasury Stock (at cost) $15.13M $17.01M $36.73M
YoY Change -57.2% -53.7%
Treasury Stock Shares 397.0K shares 276.0K shares 1.024M shares
Shareholders Equity $390.9M $373.0M $306.9M
YoY Change
Total Liabilities & Shareholders Equity $428.5M $412.9M $343.5M
YoY Change 18.66% 20.2% 14.35%

Cashflow Statement

Concept 2012 Q4 2012 Q3 2011 Q3
OPERATING ACTIVITIES
Net Income $12.34M $12.19M $9.261M
YoY Change -30.82% 31.61% 5.04%
Depreciation, Depletion And Amortization $4.700M $4.800M $4.600M
YoY Change 2.17% 4.35% 9.52%
Cash From Operating Activities $25.40M $9.400M $10.60M
YoY Change -10.56% -11.32% 715.38%
INVESTING ACTIVITIES
Capital Expenditures -$6.100M -$5.400M -$4.000M
YoY Change 205.0% 35.0% -38.46%
Acquisitions
YoY Change
Other Investing Activities -$3.000M -$5.200M -$20.00M
YoY Change -144.78% -74.0% -308.33%
Cash From Investing Activities -$9.200M -$10.50M -$24.10M
YoY Change -295.74% -56.43% -853.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.200M 6.200M -6.600M
YoY Change 340.0% -193.94% -400.0%
NET CHANGE
Cash From Operating Activities 25.40M 9.400M 10.60M
Cash From Investing Activities -9.200M -10.50M -24.10M
Cash From Financing Activities 2.200M 6.200M -6.600M
Net Change In Cash 18.40M 5.100M -20.10M
YoY Change -45.24% -125.37% -400.0%
FREE CASH FLOW
Cash From Operating Activities $25.40M $9.400M $10.60M
Capital Expenditures -$6.100M -$5.400M -$4.000M
Free Cash Flow $31.50M $14.80M $14.60M
YoY Change 3.62% 1.37% 87.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
12165000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13251000 USD
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53010000 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43571000 USD
CY2012Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16745000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-272000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9790000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-132000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-254000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16059000 USD
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
99902000 USD
CY2012Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
109696000 USD
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3514000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3234000 USD
CY2012Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
62255000 USD
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
56796000 USD
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1293000 USD
CY2012Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1146000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
189000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5000 shares
CY2011Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
295000 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2012Q3 us-gaap Assets
Assets
412907000 USD
CY2011Q4 us-gaap Assets
Assets
361112000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
260408000 USD
CY2012Q3 us-gaap Assets Current
AssetsCurrent
312608000 USD
CY2011Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
60395000 USD
CY2012Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
76768000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
557000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
288000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99590000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
127524000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78850000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66939000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11911000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
27934000 USD
CY2012Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
204292000 USD
CY2011Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
159985000 USD
CY2012Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14855000 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14855000 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13871000 shares
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14404000 shares
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
1486000 USD
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
1486000 USD
CY2011Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5396000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
13925000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
28658000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
28038000 USD
CY2012Q3 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
CY2011Q4 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
119324000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
119455000 USD
CY2011Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
40884000 USD
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
40710000 USD
CY2012Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4220000 USD
CY2011Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4081000 USD
CY2012Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4757000 USD
CY2011Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4759000 USD
CY2012Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
7148000 USD
CY2011Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
7144000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14262000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13687000 USD
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Note 2:</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">New Accounting Pronouncements:</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2011, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update number 2011-05, Comprehensive Income (Topic 220) &#8212; Presentation of Comprehensive Income ("ASU 2011-05"), to require an entity to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. ASU 2011-05 eliminates the option to present the components of other comprehensive income as part of the statement of equity. In December 2011, the FASB issued ASU No. 2011-12, Comprehensive Income (Topic 220) &#8211; Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in ASU 2011-05 ("ASU 2011-12"), which defers the effective date of those changes in ASU 2011-05 that relate to the presentation of reclassification adjustments. The adoption of ASU 2011-05 and ASU 2011-12 results in a change in how the Company presents the components of comprehensive income.</font></div></div>
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.94
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.85
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.04
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.82
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.89
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
793000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-202000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.33
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.34
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3682000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4002000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
57000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-41000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
2500000 USD
CY2012Q3 us-gaap Goodwill
Goodwill
1478000 USD
CY2011Q4 us-gaap Goodwill
Goodwill
1478000 USD
us-gaap Gross Profit
GrossProfit
106401000 USD
CY2011Q3 us-gaap Gross Profit
GrossProfit
35574000 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
40695000 USD
us-gaap Gross Profit
GrossProfit
114742000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17688000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13418000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
40443000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
42897000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13616000 USD
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4157000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1575000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13959000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5500000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-943000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1698000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
682000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2974000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1143000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-792000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2406000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
343000 shares
CY2011Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
252000 shares
CY2012Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
505000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
460000 shares
CY2012Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10423000 USD
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11419000 USD
CY2012Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13637000 USD
CY2011Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12295000 USD
CY2011Q4 us-gaap Inventory Net
InventoryNet
40423000 USD
CY2012Q3 us-gaap Inventory Net
InventoryNet
37587000 USD
CY2011Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
25227000 USD
CY2012Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
20855000 USD
CY2012Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
3095000 USD
CY2011Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2901000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
1660000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
801000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
361112000 USD
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
412907000 USD
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
28910000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
29310000 USD
CY2012Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
3816000 USD
CY2011Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
4081000 USD
us-gaap Litigation Settlement Gross
LitigationSettlementGross
2500000 USD
CY2011Q3 us-gaap Litigation Settlement Gross
LitigationSettlementGross
0 USD
us-gaap Litigation Settlement Gross
LitigationSettlementGross
0 USD
CY2012Q3 us-gaap Litigation Settlement Gross
LitigationSettlementGross
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19436000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32231000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50375000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
36051000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40931000 USD
CY2011Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
132000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
438000 USD
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
158000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
966000 USD
CY2011Q3 us-gaap Operating Expenses
OperatingExpenses
22288000 USD
us-gaap Operating Expenses
OperatingExpenses
66924000 USD
us-gaap Operating Expenses
OperatingExpenses
72283000 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
23165000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
17530000 USD
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
13286000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
39477000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
42459000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1737000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-280000 USD
CY2011Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3865000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1211000 USD
CY2011Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-283000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-154000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
255000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
409000 USD
CY2011Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
141000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
409000 USD
CY2012Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
139000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9992000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
951000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
78534000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
66330000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13208000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13761000 USD
CY2012Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2012Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2012Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5931000 USD
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6759000 USD
CY2012Q3 us-gaap Prepaid Taxes
PrepaidTaxes
7568000 USD
CY2011Q4 us-gaap Prepaid Taxes
PrepaidTaxes
5589000 USD
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
2781000 USD
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
60452000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
26935000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13214000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7021000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
909000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2220000 USD
CY2012Q3 us-gaap Profit Loss
ProfitLoss
12188000 USD
us-gaap Profit Loss
ProfitLoss
28938000 USD
us-gaap Profit Loss
ProfitLoss
26827000 USD
CY2011Q3 us-gaap Profit Loss
ProfitLoss
9261000 USD
CY2012Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
193337000 USD
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
182950000 USD
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
83641000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
83048000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
509000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-143000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2988000 USD
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1877000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6420000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8410000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
300877000 USD
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
329815000 USD
CY2012Q3 us-gaap Revenues
Revenues
81405000 USD
us-gaap Revenues
Revenues
225725000 USD
us-gaap Revenues
Revenues
234197000 USD
CY2011Q3 us-gaap Revenues
Revenues
76458000 USD
CY2011Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
76317000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
233788000 USD
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
81266000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
225316000 USD
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20177000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
63873000 USD
CY2011Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20411000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
63004000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2998000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4361000 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
320577000 USD
CY2012Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
373033000 USD
CY2012Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
451000 shares
CY2011Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
984000 shares
CY2012Q3 us-gaap Treasury Stock Value
TreasuryStockValue
17009000 USD
CY2011Q4 us-gaap Treasury Stock Value
TreasuryStockValue
35348000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14169000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14613000 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14826000 shares
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14184000 shares
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13932000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14321000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13826000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14153000 shares
CY2012Q3 icui Debt Securities Maturity Date Range High
DebtSecuritiesMaturityDateRangeHigh
2043
CY2012Q3 icui Debt Securities Maturity Date Range Low
DebtSecuritiesMaturityDateRangeLow
2012
icui Increase Decrease In Prepaid And Deferred Income Taxes
IncreaseDecreaseInPrepaidAndDeferredIncomeTaxes
-6802000 USD
icui Increase Decrease In Prepaid And Deferred Income Taxes
IncreaseDecreaseInPrepaidAndDeferredIncomeTaxes
-2194000 USD
icui Provision For Warranty And Returns
ProvisionForWarrantyAndReturns
291000 USD
icui Provision For Warranty And Returns
ProvisionForWarrantyAndReturns
0 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Period End Date
DocumentPeriodEndDate
2012-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000883984
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14586369 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
ICU MEDICAL INC/DE

Files In Submission

Name View Source Status
0000883984-12-000103-index-headers.html Edgar Link pending
0000883984-12-000103-index.html Edgar Link pending
0000883984-12-000103.txt Edgar Link pending
0000883984-12-000103-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
icui-20120930.xml Edgar Link completed
icui-20120930.xsd Edgar Link pending
icui-20120930_cal.xml Edgar Link unprocessable
icui-20120930_def.xml Edgar Link unprocessable
icui-20120930_lab.xml Edgar Link unprocessable
icui-20120930_pre.xml Edgar Link unprocessable
icui-ex311_20120930x10q.htm Edgar Link pending
icui-ex312_20120930x10xq.htm Edgar Link pending
icui-ex321_20120930x10xq.htm Edgar Link pending
icui0930201210-q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending